Edgestream Partners, L.P. Arrowhead Pharmaceuticals, Inc. Transaction History
Edgestream Partners, L.P.
- $3.48 Billion
- Q2 2025
A detailed history of Edgestream Partners, L.P. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 30,804 shares of ARWR stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,804
Previous 305,507
89.92%
Holding current value
$1.19 Million
Previous $3.89 Million
87.51%
% of portfolio
0.01%
Previous 0.14%
Shares
6 transactions
Others Institutions Holding ARWR
# of Institutions
327Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$603 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$597 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$408 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$245 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$201 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...